These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15001665)

  • 41. [The correlation between the derivatives of the arachidonic acid cascade and oral pathology. A review of the literature].
    Piattelli A; Trisi P
    Minerva Stomatol; 1990 Jan; 39(1):19-27. PubMed ID: 2109823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular evolution of receptors for eicosanoids.
    Toh H; Ichikawa A; Narumiya S
    FEBS Lett; 1995 Mar; 361(1):17-21. PubMed ID: 7890033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of mitochondria in programmed cell death mediated by arachidonic acid-derived eicosanoids.
    Yin H; Zhou Y; Zhu M; Hou S; Li Z; Zhong H; Lu J; Meng T; Wang J; Xia L; Xu Y; Wu Y
    Mitochondrion; 2013 May; 13(3):209-24. PubMed ID: 23063711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polyunsaturated fatty acids and inflammation.
    Calder PC
    Prostaglandins Leukot Essent Fatty Acids; 2006 Sep; 75(3):197-202. PubMed ID: 16828270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of prostaglandin D2, 15-deoxy-Delta12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats.
    Almishri W; Cossette C; Rokach J; Martin JG; Hamid Q; Powell WS
    J Pharmacol Exp Ther; 2005 Apr; 313(1):64-9. PubMed ID: 15590767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells.
    Harizi H; Gualde N
    Tissue Antigens; 2005 Jun; 65(6):507-14. PubMed ID: 15896197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5-Oxo-ETE receptor antagonists.
    Gore V; Patel P; Chang CT; Sivendran S; Kang N; Ouedraogo YP; Gravel S; Powell WS; Rokach J
    J Med Chem; 2013 May; 56(9):3725-32. PubMed ID: 23581530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New intercellular lipid mediators and their GPCRs: an update.
    Im DS
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):53-6. PubMed ID: 19442546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Testing and typing of eicosanoid-patterns.
    Schäfer D
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():47-64. PubMed ID: 17244954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-Oxo-ETE/OXER1: A Link between Tumor Cells and Macrophages Leading to Regulation of Migration.
    Kalyvianaki K; Salampasi EM; Katsoulieris EN; Boukla E; Vogiatzoglou AP; Notas G; Castanas E; Kampa M
    Molecules; 2023 Dec; 29(1):. PubMed ID: 38202807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Guidelines on eicosanoid nomenclature.
    Eicosanoids; 1989; 2(2):65-8. PubMed ID: 2627475
    [No Abstract]   [Full Text] [Related]  

  • 52. Structure-activity relationship study of β-oxidation resistant indole-based 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) receptor antagonists.
    Ye Q; Chourey S; Wang R; Chintam NR; Gravel S; Powell WS; Rokach J
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4770-4776. PubMed ID: 28943042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular biology of eicosanoids and atherogenesis.
    Praticò D; Dogné JM
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1079-89. PubMed ID: 19764861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolism of 5-hydroxy-6,8,11,14-eicosatetraenoic acid by human endothelial cells.
    Erlemann KR; Cossette C; Gravel S; Stamatiou PB; Lee GJ; Rokach J; Powell WS
    Biochem Biophys Res Commun; 2006 Nov; 350(1):151-6. PubMed ID: 16997273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of novel peptide agonists from a random peptide library for a 5-oxo-ETE receptor, a receptor for bioactive lipids.
    Sasaki Y; Tsujii T; Takeda S; Obinata H; Izumi T; Yamada K; Katakai R
    J Pept Sci; 2008 Dec; 14(12):1251-8. PubMed ID: 18752253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation.
    Boyce JA
    Immunol Rev; 2007 Jun; 217():168-85. PubMed ID: 17498059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative analysis of peritoneum and tumor eicosanoids and pathways in advanced ovarian cancer.
    Freedman RS; Wang E; Voiculescu S; Patenia R; Bassett RL; Deavers M; Marincola FM; Yang P; Newman RA
    Clin Cancer Res; 2007 Oct; 13(19):5736-44. PubMed ID: 17908963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors.
    Noble F; Wank SA; Crawley JN; Bradwejn J; Seroogy KB; Hamon M; Roques BP
    Pharmacol Rev; 1999 Dec; 51(4):745-81. PubMed ID: 10581329
    [No Abstract]   [Full Text] [Related]  

  • 59. [Commission of biochemical nomenclature (CBN) of the International Union of Pure and Applied Chemistry and the International Union of Biochemistry (IUPAC--IUB). Notation on a letter for amino acid sequences, proposed rules].
    Bull Soc Chim Biol (Paris); 1969 Jan; 50(10):1577-82. PubMed ID: 5799145
    [No Abstract]   [Full Text] [Related]  

  • 60. X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes.
    Vanhoutte PM; Humphrey PP; Spedding M
    Pharmacol Rev; 1996 Mar; 48(1):1-2. PubMed ID: 8685244
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.